Gao N, Yang AQ, Xu HR, Li L. Malignant fibrous histiocytoma of the axilla with breast cancer: A case report. World J Clin Cases 2022; 10(34): 12678-12683 [PMID: 36579098 DOI: 10.12998/wjcc.v10.i34.12678]
Corresponding Author of This Article
Liang Li, Doctor, Chief Physician, Department of Breast Surgery, Zibo Central Hospital, No. 54 Communist Youth League West Road, Zhangdian District, Zibo 255000, Shandong Province, China. liliangzibo@126.com
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Dec 6, 2022; 10(34): 12678-12683 Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12678
Malignant fibrous histiocytoma of the axilla with breast cancer: A case report
Ning Gao, Ai-Qing Yang, Hui-Rong Xu, Liang Li
Ning Gao, Liang Li, Department of Breast Surgery, Zibo Central Hospital, Zibo 255000, Shandong Province, China
Ai-Qing Yang, Zibo Center for Disease Control and Prevention, Zibo 255000, Shandong Province, China
Hui-Rong Xu, Department of Pathology, Zibo Central Hospital, Zibo 255000, Shandong Province, China
Author contributions: Gao N contributed to the conception of the study and wrote the manuscript; Yang AQ and Xu HR contributed significantly to the data acquisition; Li L helped perform the manuscript revision and gave approval of the final version.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Liang Li, Doctor, Chief Physician, Department of Breast Surgery, Zibo Central Hospital, No. 54 Communist Youth League West Road, Zhangdian District, Zibo 255000, Shandong Province, China. liliangzibo@126.com
Received: July 14, 2022 Peer-review started: July 14, 2022 First decision: August 4, 2022 Revised: August 14, 2022 Accepted: November 2, 2022 Article in press: November 2, 2022 Published online: December 6, 2022 Processing time: 140 Days and 21.8 Hours
Abstract
BACKGROUND
Multiple primary malignant neoplasms refer to multiple tumors with different origins. They may be synchronous or metachronous. The incidence is 0.73%– 11.7%. Synchronous cases of breast cancer with sarcoma are rare.
CASE SUMMARY
Here, we report a 78-year-old female patient admitted to hospital after accidental discovery of a left axillary mass. Preoperative examination revealed a breast mass. Pathology showed left breast cancer and left axillary sarcoma. The patient underwent surgery, endocrine therapy and radiotherapy. She has been followed up for 1 year, and no local recurrence or distant metastasis was observed.
CONCLUSION
Attention should be paid to multiple primary malignant neoplasms, not limited to the current diagnosis and analysis, avoiding missed diagnosis and misdiagnosis.
Core Tip: Multiple primary malignant neoplasms refer to multiple tumors with different origins. They may be synchronous or metachronous, with an incidence of 0.73%–11.7%. Synchronous cases of breast cancer with sarcoma are rare. In clinical practice, attention should be paid to multiple primary malignant neoplasms, not limited to the current diagnosis and analysis, avoiding missed diagnosis and misdiagnosis. For patients whose clinical symptoms cannot be explained by a single tumor, the possibility of multiple primary malignant neoplasms should be considered, and comprehensive examinations should be performed to achieve early diagnosis and treatment.
